NewsStay Updated with the Latest News from 3billion.
3billion Inc.
3billion is dedicated to creating a world where patients with rare diseases are not neglected in diagnosis and treatment.
3billion selected as a finalist of the Novartis Korea’s Health X-Challenge Seoul
News | 22. 01. 11
International Case Reviews with Kuala Lumpur Hospital
Webinar | 21. 09. 08
3billion announces pathogenicity predictor ‘3Cnet’
News | 21. 07. 30
3billion looks to 2022 IPO, expansion into drug discovery
News | 21. 04. 19
Rare disease screening firm 3Billion closes $13M Series C financing
News | 21. 03. 26
3billion aims for the global market by IPO
News | 20. 10. 12
